Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,040 JPY | +0.49% | -2.11% | -6.03% |
2023 | HABA Laboratories,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
2021 | HABA Laboratories,Inc.(JASDAQ:4925) dropped from S&P Global BMI Index | CI |
Sales 2022 | 12.91B 82.15M | Sales 2023 | 12.04B 76.61M | Capitalization | 8.81B 56.07M |
---|---|---|---|---|---|
Net income 2022 | -269M -1.71M | Net income 2023 | -707M -4.5M | EV / Sales 2022 | 0.39 x |
Net cash position 2022 | 3.09B 19.69M | Net cash position 2023 | 2.78B 17.72M | EV / Sales 2023 | 0.5 x |
P/E ratio 2022 |
-30.4
x | P/E ratio 2023 |
-12.5
x | Employees | 654 |
Yield 2022 |
1.85% | Yield 2023 |
1.72% | Free-Float | 56.05% |
1 day | +0.49% | ||
1 week | -2.11% | ||
Current month | -1.97% | ||
1 month | +0.74% | ||
3 months | -2.02% | ||
6 months | -9.01% | ||
Current year | -6.03% |
Managers | Title | Age | Since |
---|---|---|---|
Issei Miyazaki
CEO | Chief Executive Officer | 61 | 13-09-30 |
Noriko Koyanagi
CHM | Chairman | 78 | 15-05-31 |
Chief Tech/Sci/R&D Officer | 59 | 20-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tsunekazu Umeda
BRD | Director/Board Member | 78 | 00-05-31 |
Noriko Koyanagi
CHM | Chairman | 78 | 15-05-31 |
Issei Miyazaki
CEO | Chief Executive Officer | 61 | 13-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 2,040 | +0.49% | 3 800 |
24-06-10 | 2,030 | -1.22% | 3,700 |
24-06-07 | 2,055 | -0.48% | 2,300 |
24-06-06 | 2,065 | -0.53% | 3,000 |
24-06-05 | 2,076 | -0.14% | 400 |
Delayed Quote Japan Exchange, June 11, 2024 at 02:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-6.03% | 48.91M | |
+0.17% | 260B | |
+16.33% | 19.96B | |
0.00% | 19.45B | |
+19.21% | 12.92B | |
+22.83% | 7.85B | |
+10.63% | 5.95B | |
-11.96% | 3.9B | |
-1.37% | 3.82B | |
-20.14% | 3.68B |
- Stock Market
- Equities
- 4925 Stock